Please assess the completion status of the following clinical trial:

Trial Title: Diuretics and Angiotensin-Receptor Blocker Agents in Patients With Stage I Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients older than 40 years of age with stage I hypertension~Exclusion Criteria:~* low life expectancy~* other indications for the use of diuretics, such as cardiovascular disease~* intolerance to the study drugs~* pregnancy

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Chlorthalidone plus amiloride (Type: ACTIVE_COMPARATOR): Oral Chlorthalidone plus amiloride up to 25 e 5 mg daily for 18 months
- losartan (Type: EXPERIMENTAL): Oral losartan up to 100 mg daily, once a day, for 18 month

Based on this trial design, predict the completion outcome and termination type (if applicable).